Yescarta IV injection contains Axicabtagene Silorucel (YJ code: 4900405X1024, per patient) and is manufactured by Gilead Science. It is a CD19-directed chimeric antigen receptor T cell (CAR T) therapy approved for adults with certain forms of large B-cell lymphoma and follicular lymphoma that are relapsed or refractory.
Yescarta IV injection
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).